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ÖZET
Endemik Centaurea kilaea Boiss. türünün insan tümör 
hücre dizilerine karşı in vitro antiproliferatif aktivitesi 
Amaç: Bu çalışmada, Centaurea kilaea Boiss. (Asteraceae) bitkisinin ile-
ride üzerinde antiproliferatif aktivite yönlendirmeli madde izolasyonu 
çalışması yapılacak olan aktif ekstresinin belirlenmesi amaçlanmaktadır. 
Bu nedenle C. kilaea türünün toprak üstü kısımlarından elde edilen hep-
tan (CKH), kloroform (CKC) ve alt fraksiyonları (CKCSI, CKCSII, CKCSIII) ile 
metanol ekstresinin (CKM) farklı kanserli hücre hatları üzerinde aktivite-
leri araştırılarak en iyi antiproliferatif aktivite gösteren ekstresinin ortaya 
çıkarılması planlanmaktadır.
Yöntem: Antiproliferatif aktivite üç insan kanser hücre hattı üzerinde 
(Hela: Serviks kanseri hücre dizisi, MCF-7: Meme kanseri hücre dizisi, PC-3: 
Prostat kanseri hücre dizisi) MTT deneyi aracılığıyla ölçüldü.
Bulgular: CKC, 53.07; 68.64 µg/ml İK50 değerleriyle sırasıyla Hela ve 
MCF-7 hücre dizilerine karşı en yüksek antiproliferatif aktiviteyi sergile-
miştir. CKC ve CKM ise PC-3 hücre hattı üzerinde en yüksek antitümoral 
aktivite göstermişlerdir (sırasıyla İK50: 73.92; 70.11 µg/ml). Aynı zamanda 
aktif kloroform ekstresinin alt fraksiyonunun (CKCSII), 60.75 ve 60.70 µg/
ml İK50 değeriyle sırasıyla Hela ve MCF-7 hücre dizilerine karşı orta dere-
cede antiproliferatif aktiviteye sahip olduğu bulunmuştur.
Sonuç: Bu çalışma CKC ve CKCSII ekstrelerinin, yeni antitümoral aktiviteye 
sahip bileşiklerin biyoaktivite yönlendirmeli fraksiyonlama aracılığıyla 
izolasyonu için iyi birer aday olduklarını gösterir. Aynı zamanda bulguları-
mız, başka Centaurea türleri üzerinde yapılmış olan çalışmalarla benzerlik 
göstererek Centaurea türlerinin antikanser aktiviteye sahip oldukları 
gerçeğini doğrulamaktadır. Ayrıca aktif çıkan ekstre farklı hücre hatları 
üzerinde de denenebilir.
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ABS TRACT
In vitro antiproliferative activity of Endemic Centaurea 
kilaea Boiss. against Human Tumor Cell Lines
Objective: In this study, it is aimed to determine the active extract on 
which substance isolation through bioactivity-guided method is to be 
performed in the future. Therefore, it is planned to reveal the extract 
exhibiting the highest antiproliferative activity by investigating the 
activities of heptane (CKH), chloroform (CKC), sub-fractions of active 
chloroform (CKCSI, CKCSII, CKCSIII) and methanol extracts (CKM) obtained 
from the aerial parts of Centaurea kilaea Boiss. (Asteraceae) on different 
cancerous cell lines.
Method: Antiproliferative activity was measured against three 
human cancer cell lines (Hela; cervix adenocarcinoma, MCF-7; breast 
adenocarcinoma, PC-3; prostate adenocarcinoma) using MTT assay.
Results: CKC exhibited the greatest antiproliferative activity with IC50 of 
53.07; 68.64 µg/ml against Hela and MCF-7 cells, respectively, while CKC 
and CKM showed the highest antitumor activity against PC-3 cell (73.92; 
70.11 µg/ml, respectively). Also, a sub-fraction II of active chloroform 
extract (CKCSII) demonstrated moderate antiproliferative activity with IC50 
values of 60.75 and 60.70 µg/ml against Hela and MCF-7 cells, respectively.
Conclusion: The results show that CKC and CKCSII are good candidates 
for further bioactivity-guided fractionation in the search for new active 
antitumor compounds. Also, these findings confirm other results that 
have been reported in the literature relating to antiproliferative activities 
of different Centaurea species. Furthermore, active extracts would be 
tested on different tumor cell lines.
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 INTRODUCTION
 New drugs exhibiting antitumor activity are needed 
worldwide due to escalating cancer cases. This requirement 
could be met either by producing new molecules or by 
isolating new substances from the plant. The great majority 
of the drugs used in cancer treatment are mainly obtained 
either from substances isolated from plants, from 
modification of natural molecules or from main structure of 
compounds of the natural origin. Therefore; it is so 
important to maintain research on the plants exhibiting 
anticancer activity in the discovery of new molecules (1). 
 Centaurea kilaea Boiss. (Asteraceae) is one of the 205 
taxon of the genus Centaurea growing wild in Turkey (2-4). 
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It is reported that Centaurea species are rich in flavonoids 
and sesquiterpene lactones in a previous study (5). In 
traditional medicine, C. species are used for fever, menstrual 
disorders, vaginal candidiasis, the treatment of liver, kidney 
and ulcer diseases, as antidiarrheal, stomachic, tonic, 
appetitive, antidiabetic, antipyretic, also as a diuretic and 
expectorant (6,7). Antiproliferative activity studies 
conducted on some Centaurea species in recent years have 
found that various extracts of these species significantly 
have antitumor activity (8-13). In this study, the different 
extracts and fractions of active extract from aerial parts of 
C.kilaea were tested for antiproliferative activity against 
three human cancer cell lines (Hela; cervix adenocarcinoma, 
MCF-7;  breast adenocarcinoma, PC-3;  prostate 
adenocarcinoma) using MTT assay.
 MATERIALS AND METHODS 
 Plant Material 
 Plant samples were collected in the flowering periods 
from the Catalca region of Istanbul in 2009 and identified 
by Dr. Gizem Bulut, a botanist of the Faculty of Pharmacy, 
University of Marmara. Voucher specimens were deposited 
in the Herbarium of the Faculty of Pharmacy, Marmara 
University (MARE No: 11712).
 Extraction 
 Dried aerial parts of C. kilaea (1595 g) were extracted 
separately in n-heptane, chloroform and methanol using 
maceration method. Also, active chloroform extract (20 g) 
was subjected to a silica gel column (800 g) and eluted by 
gradient elution (Hexane-CHCI3-CH3OH) to afford 20 
fractions. Fractions were combined according to their TLC 
behaviour to yield CKCSI (F4-10), CKCSII (F11-14) and CKCSIII 
(F15-20). All extracts were filtered, concentrated and dried 
under vacuum on a rotary evaporator at 40°C and stored in 
a refrigerator for further analysis.
 MTT test
 The extracts (CKH, CKC, CKM, CKCSI, CKCSII, CKCSIII) 
were tested for their cytotoxic activities. Cell viability and 
cytotoxic activity profile of the extracts were analyzed using 
the MTT assay (14-16). MTT is cleaved to formazan by the 
“succinate-tetrazolium reductase” system (EC 1.3.99.1) 
which belongs to the mitochondrial respiratory chain and is 
active only in viable cells. Different cell lines were used for 
the determination of cytotoxic activity [HeLa; (ATCC®, CCL-
2™), MCF-7 (ATCC®, HTB-22™), PC-3; (ATCC®, CRL-1435™)]. 
The cells were cultured with DMEM (Dulbecco’s Modified 
Eagle Medium) supplemented with 10% FBS (Fetal bovine 
serum), 1% L-Glutamine and antibiotic solutions (penicillin-
streptomycin-amphotericin).
 Cytotoxicity testing in vitro was done by the method of 
modified Woerdenbag et al. (15,16). The MTT metabolic 
assay was carried out in seeded at the density of 1x104 cells/
well in 96-well flat-bottom cell culture plates with 100 μL of 
opti-MEM and 24-48 hours incubation at 37ºC, 5% CO2.. The 
following day, media was aspirated and the extracts were 
dissolved in DMSO and diluted with medium before they 
were added to the cell cultures at the different concentrations 
(7,5-100 µg/ml). Cells were incubated for 48 hrs at 37ºC, 5% 
CO2. After the incubation period 10μL of the MTT labelling 
reagent [final concentration 0.5 μg/mL (Cell proliferation kit 
MTT, Roche, Germany)] was added to each well. The cultures 
were incubated for 4-12 hours in a humidified atmosphere 
(e.g. 37ºC, 5.0% CO2) and 100μL of the solubilization buffer 
was added into each well. The plate was allowed to stand 
overnight in the incubator in a humidified atmosphere (e.g. 
37ºC, 5.0% CO2), the formazan precipitates were solubilized. 
Absorbance of the formazan product was measured 
spectrophotometrically at 550 and 690 nm. 
 Statistical Analysis
 The data were reported as means±standard deviations 
and analysed by one-way analysis of variance (ANOVA) 
followed by the Tukey’s multiple comparison tests using 
GraphPad Prism 5. Differences between means at p<0.05 
level were considered significant.
 RESULTS
 
 The antiproliferative activity of different extracts of 
C.kilaea were evaluated on three cancer cell lines (Hela, 
MCF7 and PC-3). All extracts at the concentration of 100 µg/
ml inhibited three cancer cell lines growth about by 50% 
compared to a control (p<0.0001) (Figure 1). 
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 According to the American National Cancer Institute 
(NCI), the IC50 values < 20 μg/ml, 20-100 μg/ml and > 100 
μg/ml are considered as active, moderately active and 
inactive, respectively (17). All extracts, except for CKH and 
CKM against Hela, CKCSI against PC-3, represented 
moderate antiproliferative activity.
 A low IC50 value, the concentration that causes 50% 
growth inhibition, indicates high activity. As shown in Table 
1, CKC exhibited the greatest antiproliferative activity with 
IC50 of 53.07; 68.64 µg/ml against Hela and MCF-7 cells, 
respectively, while CKC and CKM showed the highest 
antitumor activity against PC-3 cell (73.92; 70.11 µg/ml, 
respectively). Also, CKCSII demonstrated moderate 
antiproliferative activity with IC50 values of 60.75 and 60.70 
µg/ml against Hela and MCF-7 cells, respectively.
 DISCUSSION
 In a study performed by a team of researchers from NCI, 
7500 plant extracts were monitored and found that the 
great majority of active extracts had been obtained from 
species belonging to family Asteraceae, which is rich in 
sesquiterpene lactones (18).
 In recent years, studies on the antiproliferative activity 
Table 1: The antiproliferative activity (IC50 µg/ml) of various extracts of C.kilaea on cancer cell lines 
Extracts/fractions
IC50 (µg/ml)*
MCF-7 Hela PC-3
CKH 90.82±1.70 103.8±1.51 90.25±2.08
CKC 68.64±1.37 53.07±0.70 73.92±2.12
CKM 91.53±1.11 102.1±3.01 70.11±1.65
CKCSI 90.17±3.15 98.28±1.48 100.9±3.86
CKCSII 60.70±2.07 60.75±1.40 96.08±1.64
CKCSIII 89.81±3.89 83.51±0.80 86.62±0.67
- Each value in the table is represented as mean±SD (n=3)
- *IC50 is the concentration that causes 50% growth inhibition.
- Abbreviations; CKH: Heptane extract, CKC: Chloroform extract, CKM: Methanol extract, CKCSI: Subfraction-I of chloroform extract,
CKCSII: Subfraction-II of chloroform extract, CKCSIII: Subfraction-III of chloroform extract, of Centaurea kilaea.
Figure 1: The effects of C.kilaea on proliferation of cancer cells at the concentration of 100 µg/ml
***p<0.0001 vs control
- The percentage values on graph indicate rate of growth inhibition.
- Abbreviations; CKH: Heptane extract, CKC: Chloroform extract, CKM: Methanol extract, CKCSI: Subfraction-I of chloroform extract,
CKCSII: Subfraction-II of chloroform extract, CKCSIII: Subfraction-III of chloroform extract, of Centaurea kilaea.
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of Centaurea species, a member of Asteraceae family have 
been frequently conducted. In previous antiproliferative 
activity studies performed on different Centaurea species, it 
was found that chloroform extracts of these species, which 
are rich in flavonoids and terpenoids, generally had 
significant anti-cancer activity. 
 Csupor et al. (2009) reported that various extracts 
obtained from different parts of C.biebersteinii and C.jacea, 
especially chloroform fractions of aqueous methanol 
extract, exhibit high antiproliferative activity on Hela, MCF-
7, A431 human cancer cell lines (8). 
 In bioactivity studies done on C. arenaria by Csapi et al. 
(2010) and C. bruguierana subsp. belangerana by Rajabi et 
al. (2009), chloroform fractions of aqueous methanol 
extracts have been demonstrated to have antitumor 
activity (10,11).
 In another study related to antiproliferative activity-
guided isolation of active compounds from C. jacea, it was 
discovered that compounds responsible for anticancer 
activity are in the form of flavonoid (centauredin, cirsiliol, 
isokaempferide, apigenin, hispidulin) and sesquiterpene 
lactone (cnicin and 4’-acetylcnicin) (9). 
 Erel et al. (2011) found out that cinicin, a sesquiterpene 
lactone frequently existed in Centaurea species, isolated 
from chloroform extract of aerial part of C. calolepis showed 
high degree of antiproliferative activity on LLC-PK11 (pig 
kidney epithelial cell lines), SK-MEL (human malignant 
melanoma cell lines) and BT-549 (human ductal carcinoma) 
with IC50 values 23.3, 14.0 and 18.3 μM, respectively (19).
 In our present study, CKC showed similarity tothe 
studies of Csupor et al. (2009) and Forgo et al. (2012) by 
exhibiting the best antiproliferative activity. Highly 
methoxylated flavonoids and terpenoids (sesquiterpene 
lactones and triterpenes) have been isolated so far in our 
ongoing isolation studies on CKCSII. We believe that these 
compounds in CKCSII may be responsible for the 
antiproliferative activity. Therefore, in our future studies, we 
aim to detect the compounds responsible for activity, firstly 
by considering the structure elucidation of these substances 
and then, testing the effects of them, singularly or in 
combination, normal and cancerous cell lines. 
 CONCLUSION
 The results show that CKC and CKCSII are good 
candidates for further activity-guided fractionation in the 
search for new active antitumor compounds. Also, these 
findings confirm other results that have been reported in 
the literature relating to antiproliferative activities of 
different Centaurea species. Furthermore, active extracts 
would be tested on different tumor cell lines.
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